Effect of hydrocortisone therapy on severe leaky lung syndrome in ventilated preterm infants

Pediatrics International

Volumn 54, Issue 5, 2012, Pages 639-645

  Mizobuchi, Masami ^a   Iwatani, Sota ^a   Sakai, Hitomi ^a   Yoshimoto, Seiji ^a   Nakao, Hideto ^a  

^a KOBE CHILDREN S HOSPITAL   (Japan)

Author keywords

chronic lung disease; hydrocortisone; leaky lung syndrome; preterm infant; tracheal aspirate

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; HYDROCORTISONE; INTERLEUKIN 6; SURFACTANT;

ARTICLE; ARTIFICIAL VENTILATION; CAPILLARY LEAK SYNDROME; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; INCIDENCE; INFANT; LEAKY LUNG SYNDROME; LOW BIRTH WEIGHT; LUNG DISEASE; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PILOT STUDY; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SMALL FOR DATE INFANT; TRACHEA MUCUS; TRACHEAL ASPIRATION PROCEDURE; TREATMENT DURATION; VENTILATED PATIENT;

BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; BRONCHOPULMONARY DYSPLASIA; FEMALE; GESTATIONAL AGE; HUMANS; HYDROCORTISONE; INCIDENCE; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTERLEUKIN-6; LUNG; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RISK FACTORS;

EID: 84866991843     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2012.03636.x     Document Type: Article

References (30)

1. Eichenwald EC, Stark AR,. Management and outcomes of very low birth weight. N. Engl. J. Med. 2008; 358: 1700-11.
2. Sauve RS, Singhal N,. Long-term morbidity of infants with bronchopulmonary dysplasia. Pediatrics 1985; 76: 725-33.
3. Singer L, Yamashita T, Lilien L, Collin M, Baley J,. A longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birth weight. Pediatrics 1997; 100: 987-93.
4. Swischuk LE, John SD,. Immature lung problems: can our nomenclature be more specific? AJR Am. J. Roentgenol. 1996; 166: 917-18.
5. Swischuk LE, Shetty BP, John SD,. The lungs in immature infants: how important is surfactant therapy in preventing chronic lung problems? Pediatr. Radiol. 1996; 26: 508-11.
6. Swischuk LE,. Imaging of the Newborn, Infant and Young Child, 5th edn. Lippincott Williams & Wilkins, Philadelphia, PA, 2003; 36-8.
7. Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw RJ,. Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr. Res. 1996; 40: 250-6.
8. Bagchi A, Viscardi RM, Taciak V, Ensor JE, McCrea KA, Hasday JD,. Increased activity of interleukin-6 but not tumor necrosis factor-alpha in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia. Pediatr. Res. 1994; 36: 244-52.
9. Jónsson B, Tullus K, Brauner A, Lu Y, Noack G,. Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants. Arch. Dis. Child. Fetal Neonatal Ed. 1997; 77: F198-201.
10. Niu JO, Munshi UK, Siddiq MM, Parton LA,. Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia. J. Pediatr. 1998; 132: 965-70.
11. Choi CW, Kim BI, Kim HS, Park JD, Choi JH, Son DW,. Increase of interleukin-6 in tracheal aspirate at birth: a predictor of subsequent bronchopulmonary dysplasia in preterm infants. Acta Paediatr. 2006; 95: 38-43.
12. Groneck P, Götze-Speer B, Oppermann M, Eiffert H, Speer CP,. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 1994; 93: 712-18.
13. Watterberg KL, Gerdes JS, Gifford KL, Lin HM,. Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics 1999; 104: 1258-63.
14. Watterberg KL, Gerdes JS, Cole CH, et al,. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 2004; 114: 1649-57.
15. Doyle LW, Ehrenkranz RA, Halliday HL,. Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology 2010; 98: 111-17.
16. van der Heide-Jalving M, Kamphuis PJ, van der Laan MJ, et al,. Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone? Acta Paediatr. 2003; 92: 827-5.
17. Blanc WA,. Amniotic infection syndrome; pathogenesis, morphology, and significance in circumnatal mortality. Clin. Obstet. Gynecol. 1959; 2: 705-34.
18. ACOG committee opinion. Antenatal corticosteroid therapy for fetal maturation. Number 147-December 1994. Committee on Obstetric Practice. American College of Obstetricians and Gynecologists. Int. J. Gynaecol. Obstet. 1995; 48: 340-2.
19. Papile LA, Burstein J, Burstein R, Koffler H,. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J. Pediatr. 1978; 92: 529-34.
20. Walsh MC, Kliegman RM,. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr. Clin. North Am. 1986; 33: 179-201.
21. Watkinson M,. Hypertension in the newborn baby. Arch. Dis. Child. Fetal Neonatal Ed. 2002; 86: F78-81.
22. Lal MK, Manktelow BN, Draper ES, Field DJ,. Population-based study. Chronic lung disease of prematurity and intrauterine growth retardation: a population-based study. Pediatrics 2003; 111: 483-7.
23. Zeitlin J, El Ayoubi M, Jarreau PH, et al,. Impact of fetal growth restriction on mortality and morbidity in a very preterm birth cohort. J. Pediatr. 2010; 157: 733-9.
24. Watterberg KL, Scott SM,. Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia. Pediatrics 1995; 95: 120-5.
25. Watterberg KL, Gerdes JS, Cook KL,. Impaired glucocorticoid synthesis in premature infants developing chronic lung disease. Pediatr. Res. 2001; 50: 190-5.
26. Hasan J, Beharry KD, Valencia AM, Strauss A, Modanlou HD,. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease. Pediatrics 2009; 123: 1541-7.
27. Cederqvist K, Sorsa T, Tervahartiala T, et al,. Matrix metalloproteinases-2, -8, and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress. Pediatrics 2001; 108: 686-92.
28. de Blic J, Midulla F, Barbato A, et al,. Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. Eur. Respir. J. 2000; 15: 217-31.
29. Bry K, Hogmalm A, Bäckström E,. Mechanisms of inflammatory lung injury in the neonate: lessons from a transgenic mouse model of bronchopulmonary dysplasia. Semin. Perinatol. 2010; 34: 211-21.
30. Nachbaur K, Troppmair J, Bieling P, Kotlan B, König P, Huber C,. Cytokines in the control of beta-2 microglobulin release. I. In vitro studies on various haemopoietic cells. Immunobiology 1988; 177: 55-65.